Elo has dramatically expanded the utility of its Elo Access App. In its original incarnation, the app let users create and deploy health questionnaires for the purpose of on-premises access control. The upgrade will enable a slew of biometric features when the app is integrated with the Elo self-service Temperature Check Kiosk.
The new features are offered through the Premium version of Elo Access, which is available on an annual subscription basis. Those features include mask detection and temperature detection, which will allow venues to bar access to people who are not wearing a mask or who are showing symptoms of COVID-19. In the future, Elo will also add biometric authentication for registered individuals, allowing employees to prove their identities with facial recognition.
Elo Access will send an email notification to administrators when it spots someone with an elevated temperature. The app has a privacy mode and data reporting capabilities, and can be managed and configured remotely through the EloView device management platform. Organizations interested in the Kiosk can get Elo Access Premium bundled with Elo’s 15-inch Android touchscreen, an Elo Temperature Sensor Pro, and their choice of stand.
“The growing desire to get out and resume normal activities in a safe and appropriate manner is driving the need for new technology-enabled safety solutions,” said Elo CEO Craig Witsoe. “The combination of upgraded Elo Access App and temperature check kiosk provides businesses with a simple and highly visible safety check for their employees and visitors.”
Elo previously partnered with AT&T Healthcare and LifeMedID to provide self-service kiosk solutions for organizations in the healthcare industry. The company is hoping that the improved app will appeal to clients in healthcare and in other industries like retail and education. Elo is one of several companies offering temperature detection as a public safety measure, although the company noted that the Temperature Sensor Pro is not an FDA-approved device and therefore should not be used as an official diagnostic tool. The SIA has warned that non-FDA devices could create a false sense of security during the pandemic.
December 9, 2020 – by Eric Weiss